Close Menu

NEW YORK (GenomeWeb) – A team of researchers from Columbia University, Northwestern University School of Medicine, and elsewhere has identified tumor and microenvironment features in glioblastoma (GBM) brain tumors that are linked to response to immune checkpoint immunotherapy targeting PD-1.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.